Malignant Abdominal Neoplasm — Trials

Malignant Abdominal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

64 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 6
Ph III recruiting: 1
Growth YoY: —
Industry share: 20%
Top sponsor: Varian, a Siemens Healthineers Company
Termination share: 16.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05975619	A Prospective Imaging Study of the Integrated TrueBeam-HyperSight CBCT System	active not recruiting	N/A	40	Varian, a Siemens Healthineers CompanyINDUSTRY	1	Sep 9, 2026	clinicaltrials
NCT03361436	Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery	active not recruiting	Phase 1	15	OHSU Knight Cancer InstituteOTHER	1	Apr 8, 2026	clinicaltrials